Edwards Lifesciences Corp. shares dropped in late trading Tuesday after the company provided a disappointing forecast. The company reported first-quarter earnings of 96 cents a share on sales of $894.8 million. After adjusting for sales reserves, litigation expenses and other effects, the company claimed earnings of $1.22 a share on sales of $937.5 million. Analysts on average expected adjusted earnings of $1.11 a share on sales of $932.3 million, according to FactSet. The company forecast adjusted earnings of $1.05 to $1.15 in the second quarter on sales of $960 million to $1 billion. Analysts on average were projecting adjusted earnings of $1.17 a share on sales of $967 million, according to FactSet. Edwards stock declined about 8% in after-hours trading.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Latest posts by Market Watch (see all)
- London Markets: London markets falter as investors react to historic Brexit defeat - January 16, 2019
- The Wall Street Journal: American among 15 dead after militants attack upscale hotel in Kenya - January 16, 2019
- FTSE 100 slips after historic Brexit defeat - January 16, 2019